Walpar Nutritions
Ticker > Company >

Walpar Nutritions share price

Walpar Nutritions Ltd.

NSE: WALPAR SECTOR: Pharmaceuticals & Drugs  16.56 K   8   0

40.55
+0.55 (1.38%)
NSE: 18 Sep 03:40 PM

Price Summary

Today's High

₹ 42

Today's Low

₹ 40.5

52 Week High

₹ 53.3

52 Week Low

₹ 39.15

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 38.08 Cr.

Enterprise Value

₹ 37.95 Cr.

No. of Shares

0.94 Cr.

P/E

22.49

P/B

2.54

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  15.99

CASH

₹ 0.45 Cr.

DEBT

₹ 0.32 Cr.

Promoter Holding

68.52 %

EPS (TTM)

₹  1.8

Sales Growth

78.77%

ROE

9.03 %

ROCE

11.98%

Profit Growth

277.61 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year78.77%
3 Year103.73%
5 YearNA

Profit Growth

1 Year277.61%
3 Year94.64%
5 YearNA

ROE%

1 Year9.03%
3 Year5.68%

ROCE %

1 Year11.98%
3 Year7.93%

Debt/Equity

0.0237

Price to Cash Flow

12.15

Interest Cover Ratio

8.188

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 68.52 0.00
Sep 2024 68.44 0.00
Mar 2024 71.23 0.00
Sep 2023 71.46 0.00
Mar 2023 70.54 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 103.733764408963% for the Past 3 years.
  • The company has significantly decreased its debt by 2.8895 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 8.188.
  • Company’s PEG ratio is 0.0848078150777635.
  • The company has an efficient Cash Conversion Cycle of 46.2991 days.
  • The company has a high promoter holding of 68.52%.

 Limitations

  • Company has a poor ROE of 5.6828% over the past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 22.49.

Quarterly Result (All Figures in Cr.)
 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 6.07 26.76 28.7 51.31
Total Expenditure 5.61 25.7 27.92 49.55
Operating Profit 0.46 1.06 0.78 1.76
Other Income 0 0.04 0.27 0.13
Interest 0.18 0.48 0.34 0.21
Depreciation 0.12 0.28 0.25 0.21
Exceptional Items 0 0 0 0
Profit Before Tax 0.16 0.34 0.46 1.48
Tax 0.01 -0.08 0.16 0.37
Net Profit 0.15 0.42 0.29 1.11
Adjusted EPS (Rs.) 0.23 0.46 0.32 1.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.34 4.54 4.54 4.7
Total Reserves 1.44 6.49 6.78 8.64
Borrowings 2.63 1.6 1.03 0
Other N/C liabilities -0.04 -0.21 -0.16 -0.12
Current liabilities 8.29 10.72 9.51 10.16
Total Liabilities 15.66 23.15 21.7 23.38
Assets
Net Block 1.07 0.94 0.83 1.48
Capital WIP 0 0 0.02 0.02
Intangible WIP 0 0 0 0
Investments 0.06 2.93 2.84 4.7
Loans & Advances 0.6 2.32 1.81 0.03
Other N/C Assets 0.2 0.04 0.03 0.02
Current Assets 13.73 16.91 16.17 17.12
Total Assets 15.66 23.15 21.7 23.38
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.16 0.34 0.46 1.48
Adjustment 0.3 0.76 0.59 0.35
Changes in Assets & Liabilities 0.92 -1.34 0.12 1.42
Tax Paid 0 -0.07 -0.08 -0.11
Operating Cash Flow 1.38 -0.32 1.09 3.13
Investing Cash Flow -0.7 -4.58 0.46 -0.88
Financing Cash Flow -0.06 4.27 -1.52 -2.18
Net Cash Flow 0.62 -0.63 0.03 0.07

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Sep 2023% Mar 2024% Sep 2024% Mar 2025%
promoters 70.54 71.46 71.23 68.44 68.52
abhishekkumar dineshkumar... 2.97 2.88 2.88 2.88 2.88
amit vishnubhai patel 0.11 0.11 0.11 0.11 0.11
arunaben s raval 0.04 0.04 0.04 0.04 0.04
ashwin r shah 0.09 0.09 0.09 0.09 0.09
dineshkumar kantilal modi... 0.04 0.04 0.04 0.02 0.02
divyanshu subhashchandra ... 2.97 2.88 2.79 2.24 2.24
fenil prakashkumar shah 1.32 1.28 1.28 1.28 1.28
jignaben prakashkumar sha... 0.11 0.11 0.06 0.06 0.06
jigneshkumar dineshkumar ... 2.97 2.88 2.88 2.88 2.88
kalpesh pravinchandra lad... 17.18 18.36 18.36 18.36 18.36
kanan dipak shah 0.04 0.04 0.04 0.04 0.04
krunal jasubhai patel 3.72 4.03 4.03 4.03 4.11
naresh ramanlal shah 0.04 0.04 0.04 0.04 0.04
nidhi yogeshkumar shah 6.47 6.26 6.26 6.26 6.26
palakben hirenkumar shah 0.11 0.11 0.11 0.11 0.11
patel kashyap vishnubhai 0.11 0.11 0.11 0.11 0.11
payal krunalkumar patel 0.11 0.11 0.07 0.07 0.07
pragneshkumar natvarlal s... 0.11 0.11 0.11 0.11 0.11
pravinchandra narsinhlal ... 0.44 0.43 0.43 0.43 0.43
ravi g shah 0.04 0.04 0.04 0.04 0.04
ripal kanubhai patel 0.22 0.21 0.21 0.21 0.21
sejal kalpesh ladhawala 15.50 16.10 16.10 14.65 14.65
shah rakesh narharilal 0.44 0.43 0.43 0.43 0.43
tanmaykumar ashwinbhai sh... 14.53 14.06 14.06 13.31 13.31
tejal vijaykumar thakkar 0.33 0.32 0.28 0.28 0.28
vijay thakkar 0.33 0.32 0.32 0.32 0.32
yogesh ghanshyambhai shah... 0.07 0.06 0.06 0.06 0.06
dilipkumar natvarlal pate... 0.02 0.02 0.02 - -
ladhawala rushi narsinhla... 0.02 0.02 - - -
jashavantkumar premshanka... 0.04 - - - -
PARTICULARS Mar 2023% Sep 2023% Mar 2024% Sep 2024% Mar 2025%
investors 29.46 28.54 28.77 31.56 31.48
bijay pratap singh huf - 1.53 1.49 1.45 1.45
champaklal amratlal shah 1.37 1.32 1.32 1.32 1.38
dakshaben ashvinkumar sha... 1.54 1.49 1.49 1.49 1.90
shri bajrangbali ashok co... - - - 1.15 1.15
xtended business reportin... 1.81 1.75 2.22 2.22 2.22
rajesh kumar 1.94 2.90 2.64 1.15 -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Walpar Nutritions Stock Price Analysis and Quick Research Report. Is Walpar Nutritions an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Walpar Nutritions. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Walpar Nutritions has a PE ratio of 22.4915414055133 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Walpar Nutritions has ROA of 4.9307% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Walpar Nutritions has a Current ratio of 1.6852.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Walpar Nutritions has a ROE of 9.0348%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Walpar Nutritions has a Debt to Equity ratio of 0.0237 which means that the company has low proportion of debt in its capital.

  • Sales growth: Walpar Nutritions has reported revenue growth of 78.7723% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Walpar Nutritions for the current financial year is 3.43277968433626%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Walpar Nutritions is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Walpar Nutritions is Rs 1.8029. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Walpar Nutritions in Ticker for free. Also, one can get the intrinsic value of Walpar Nutritions by using Valuation Calculators, which are available with a Finology ONE subscription. 

Walpar Nutritions FAQs

Q1. What is Walpar Nutritions share price today?
Ans: The current share price of Walpar Nutritions is Rs 40.55.

Q2. What is the market capitalisation of Walpar Nutritions?
Ans: Walpar Nutritions has a market capitalisation of Rs 38.0782342 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Walpar Nutritions?
Ans: The PE ratio of Walpar Nutritions is 22.4915414055133 and the P/B ratio of Walpar Nutritions is 2.53576967332033, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Walpar Nutritions share?
Ans: The 52-week high share price of Walpar Nutritions is Rs 53.3, and the 52-week low share price of Walpar Nutritions is Rs 39.15.

Q5. Does Walpar Nutritions pay dividends?
Ans: Currently, Walpar Nutritions does not pay dividends. Dividend yield of Walpar Nutritions is around 0%.

Q6. What are the face value and book value of Walpar Nutritions shares?
Ans: The face value of Walpar Nutritions shares is Rs 10, while the book value per share of Walpar Nutritions is around Rs 15.9912. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Walpar Nutritions?
Ans: Walpar Nutritions has a total debt of Rs 0.3153 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Walpar Nutritions?
Ans: The ROE of Walpar Nutritions is 9.0348% and ROCE of Walpar Nutritions is 11.9849%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Walpar Nutritions a good buy for the long term?
Ans: The Walpar Nutritions long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Walpar Nutritions undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Walpar Nutritions appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Walpar Nutritions’s financials?
Ans: You can review Walpar Nutritions’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Walpar Nutritions
X